AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal ...
Abstract: Rate-Splitting Multiple Access (RSMA) has emerged as a powerful multiple access, interference management, and multi-user strategy for next generation communication systems. In this tutorial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results